NASDAQ · ALGN

Align Technology Inc.

$168.05 +$1.04 (+0.62%) 1D After hours
Charting by TradingView

Key Metrics

$11.96B
Market cap
27.82×
P/E · TTM
$4.10B
Revenue · TTM
$429.89M
Net income
EPS · TTM $5.84
Dividend yield —
Free cash flow $583.65M
Beta · 1Y 1.56
EBITDA · TTM $848.57M
Gross margin 67.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 5
    The stock moved +8.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$11.96B
Enterprise value—
Shares outstanding71.6M
52-wk range$122.00 – $208.31
Avg volume · 20D918.7K
Net cash —
Book value / share$56.37
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNASDAQ
About Align Technology Inc.
IPO dateJan 26, 2001
Employees20275

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E27.82
P/S2.92
P/FCF20.49
EV/EBITDA—
EV/Sales—
Graham №$86.06

Profitability

Gross 67.6%
Operating 14.5%
Net 10.5%
FCF 14.2%
ROE / ROIC 10.7% · 13.9%

Financial Health

Current ratio1.39
Quick ratio1.28
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$749.58M

Cash Flow · TTM

Operating CF $691.59M
Capex −$107.94M
Free cash flow $583.65M
Buybacks $296.05M
Dividends paid —
Shareholder yield 2.5%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

5.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$86.06 vs $168.05
Trades 2.0× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings